Grant Support

Current Grant Support

NIH/NIBIB (U01 EB029371), “Single cell profiling to define biomarkers of photoreceptor dysfunction after gene editing within PSC-derived organoids” (2019-2023). Pattnaik, Co-Investigator

NIH/NEI (R01 EY030123), “Targeting BAX as a therapeutic for protection of retinal ganglion cells” (2019-2023). Pattnaik, Co-Investigator

NIH/NEI (R01 EY022086), “Molecular genetics of age-dependent retinal degeneration” (2018-2023). Pattnaik, Co-Investigator

Foundation Fighting Blindness, “Gene editing nanomedicines to correct pathogenic mutations in the retina” (2018-2021). Pattnaik, Co-PI

Ateres Avigail, “Restoration of potassium channel function using mouse models of Lebers Congenital Amaurosis (LCA16) as a means to treat retinal channelopathies” (2018-2020). Pattnaik, PI

UW Office of the VCGRE, “Gene editing nanomedicines to correct pathogenic mutations in retinal pigmented epithelium” (2018-2020). Pattnaik, Co-PI

NIH/NICHD (T32 HD041921), “Endocrinology-reproductive physiology training grant” (2018-2020). Pattnaik, Mentor to Katie Beverley

DOD, Army & University of Pittsburgh (W81XWZH-16-0775), “A comprehensive approach to whole eye transplantation: building a scientific foundation for new therapies in vision restoration” (2016-2020). Pattnaik, Co-Investigator

NIH/NEI (R01 EY024995), “Molecular therapies for Lebers Congenital Amaurosis caused by KCNJ13 Mutations” (2015-2020). Pattnaik, PI

Retina Research Foundation, “Matthews research professorship” (2016-2019). Pattnaik, PI


Completed Grant Support

NIH/NEI & University of Iowa (R01 EY024588), “Disease mechanisms in Best Disease” (2015-2019). Pattnaik, Co-Investigator

Meriter Foundation, “Retinopathy of prematurity due to oxytocin deprivation” (2018). Pattnaik, PI

NIH/NICHD (T32HD041921), “Endocrinology-reproductive physiology training grant” (2017-2018). Pattnaik, Mentor to Nathan York

NIH/NEI (R24 EY022883), “Novel antiangiogenic peptides for treatment of exudative AMD” (2013-2018). Pattnaik, Co-Investigator

Meriter Foundation, “Specificity of oxytocin induced retinopathy” (2017). Pattnaik, PI

NIH/NEI, “Sigma-1 chaperone-mediated in vivo neuroprotection in the retina” (2012-2017). Pattnaik, Co-Investigator

NIH/NEI, “ARVO travel award” (2016). Pattnaik, Mentor to Nathan York

Meriter Foundation, “Effect of oxytocin on retina angiogenesis as a measure of ROP” (2016).  Pattnaik, PI

Anonymous Donor, “LCA16 research” (2013-2016).  Pattnaik, PI

NIH/NHLBI (R01 HL079020), “Pregnancy/NO induced changes in UAE Ca2+signaling” (2007-2016). Pattnaik, Co-Investigator

Meriter Foundation, “Oxytocinergic signaling in the eye and retinopathy of prematurity: proof of principle” (2015).  Pattnaik, PI

Sigma Xi, the Scientific Research Society (Undergraduate Research Grant, Michelle Chiu), “Uncovering oxytocin signaling in a single cell” (2014-2015). Pattnaik, Mentor

NIH/NEI (R01 EY022086), “Molecular genetics of age-dependent retinal degeneration” (2012-2015). Pattnaik, Co-Investigator

Meriter Foundation, “Oxytocinergic signaling in the eye: its contribution to Retinopathy of Prematurity” (2014).  Pattnaik, PI

University of Wisconsin Hilldale Fellow (2014). Pattnaik, Mentor for Michelle Chiu

University of Wisconsin Medical School Shapiro Summer Research Program (2014). Pattnaik, Mentor for Vladimer Bakhutashvill

Meriter Foundation, “Oxytocinergic signaling in the eye: its contribution to Retinopathy of Prematurity” (2013).  Pattnaik, PI

Macula Vision Research Foundation, “The role of birth-related hormones in retinopathy of prematurity” (2011-2013).  Pattnaik, Co-Investigator

University of Wisconsin, “Rebecca Meyer Brown Professorship” (2009-2013).  Pattnaik, PI

Meriter Foundation, “Oxytocin signaling in the Retina Pigment Epithelium (RPE) cells and its contribution to Retinopathy of Prematurity (ROP)” (2012).  Pattnaik, PI

Meriter Foundation, “The role of birth-related hormones in retinopathy of prematurity” (2011).  Pattnaik, PI

Fight for Sight (Summer Student Fellowship, Simran Brar), “Understanding Best’s Disease mechanisms due to a cytoplasmic point mutation” (2011).  Pattnaik, Mentor

NIH/NCRR and University of Wisconsin Institute for Clinical and Translational Research (UL1 TR025011), “Human RPE cell electrophysiology to model eye-disease” (2010-2011).  Pattnaik, PI